The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

This publication has 37 references indexed in Scilit:

• Development of an Adjuvant to Enhance the Immune Response to Influenza Vaccine in the Elderly
  Biologicals, 1997
• Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin
  Vaccine, 1996
• Induction of Mucosal Antibodies by Live Attenuated and Inactivated Influenza Virus Vaccines in the Chronically III Elderly
  The Journal of Infectious Diseases, 1996
• Vaccine-Induced Antibodies to Heterologous Influenza A H1N1 Viruses: Effects of Aging and “Original Antigenic Sin”
  The Journal of Infectious Diseases, 1994
• Developments in mucosal influenza virus vaccines
  Vaccine, 1994
• Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose—response study in elderly nursing-home residents and young volunteers
  Vaccine, 1993
• Comparative Trial of Large-Particle Aerosol and Nose Drop Administration of Live Attenuated Influenza Vaccines
  The Journal of Infectious Diseases, 1993
• Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382)
  Vaccine, 1992
• Local and systemic influenza haemagglutinin-specific antibody responses following aerosol and subcutaneous administration of inactivated split influenza vaccine
  Vaccine, 1992
• Intranasal immunization with proteoliposomes protects against influenza
  Vaccine, 1989